6533b85ffe1ef96bd12c2681

RESEARCH PRODUCT

Fatty liver and mortality: a cohort population study in South Italy

Marisa ChiloiroAnna Maria CisterninoAntonio LogroscinoValeria TutinoAlberto Rubén OsellaGiovanni MisciagnaVito GuerraRocco GuerraOrnella RotoloRosa InguaggiatoMaria NotarnicolaNicola VeroneseRossella DonghiaGioacchino LeandroGiampiero De LeonardisCaterina BonfiglioRosa ReddavideMaria Gabriella Caruso

subject

AdultMalemedicine.medical_specialtyEpidemiologyPopulationhepatobiliary disease03 medical and health sciences0302 clinical medicineRisk FactorsCause of DeathInternal medicineHumansMedicine1506Prospective StudiesRisk factoreducationgeneral endocrinologyAgedAged 80 and overeducation.field_of_studybusiness.industryResearchFatty liverHepatobiliary diseaseGeneral MedicineMiddle Agedmedicine.diseasemortality1692Fatty LiverSurvival RateItalyPopulation Surveillance030220 oncology & carcinogenesisCohortPopulation studyFemale030211 gastroenterology & hepatologyAlcoholic fatty liverSteatosisbusiness

description

ObjectiveAlcoholic fatty liver (AFLD) and non-alcoholic fatty liver (NAFLD) are two common conditions. However, if they can increase the risk of death is poorly explored. We therefore aimed to investigate the potential association between the presence and severity of liver steatosis and mortality in a large sample of older people.DesignProspective.SettingCommunity.ParticipantsWomen and men randomly sampled from the electoral rolls of the population of Castellana Grotte, a town in Southern Italy (Apulia region) between 2005 and 2006. Among 1942 initially contacted, 1708 (=87.9%) participated to the baseline survey (Multicentrica Colelitiasi III (MICOL III)). This specific study included 1445 older participants (mean age=65.2 years, females=44.2%).ExposureNAFLD or AFLD.Primary and secondary outcomesMortality (all-cause and specific-cause).ResultsAfter a median of 12 years, 312 participants (=21.6%) died. After adjusting for nine potential confounders, the presence of steatosis was not associated with any increased risk of death in both NAFLD and AFLD. The severity of liver steatosis was not associated with any increased risk of mortality in NAFLD, while in AFLD, the presence of moderate steatosis significantly increased the risk of overall (HR=2.16; 95% CI 1.19 to 3.91) and cancer-specific (HR=3.54; 95% CI 1.16 to 10.87) death.ConclusionsLiver steatosis is not associated with any increased risk of death in NAFLD, while moderate steatosis could be a risk factor for mortality (particularly due to cancer) in people affected by AFLD.

https://doi.org/10.1136/bmjopen-2018-027379